BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11754005)

  • 1. Secretory phospholipases A2 induce cytokine release from blood and synovial fluid monocytes.
    Triggiani M; Granata F; Oriente A; Gentile M; Petraroli A; Balestrieri B; Marone G
    Eur J Immunol; 2002 Jan; 32(1):67-76. PubMed ID: 11754005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type IIA secretory phospholipase A2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes.
    Bidgood MJ; Jamal OS; Cunningham AM; Brooks PM; Scott KF
    J Immunol; 2000 Sep; 165(5):2790-7. PubMed ID: 10946311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of release of secretory nonpancreatic phospholipase A2 from human articular chondrocytes.
    Pruzanski W; Bogoch E; Katz A; Wloch M; Stefanski E; Grouix B; Sakotic G; Vadas P
    J Rheumatol; 1995 Nov; 22(11):2114-9. PubMed ID: 8596153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory phospholipases A2 induce beta-glucuronidase release and IL-6 production from human lung macrophages.
    Triggiani M; Granata F; Oriente A; De Marino V; Gentile M; Calabrese C; Palumbo C; Marone G
    J Immunol; 2000 May; 164(9):4908-15. PubMed ID: 10779801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipase A2-activating protein induces the synthesis of IL-1 and TNF in human monocytes.
    Bomalaski JS; Ford T; Hudson AP; Clark MA
    J Immunol; 1995 Apr; 154(8):4027-31. PubMed ID: 7706741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of extracellular release of proinflammatory secretory phospholipase A2 (sPLA2) by sulfasalazine: a novel mechanism of anti-inflammatory activity.
    Pruzanski W; Stefanski E; Vadas P; Ramamurthy NS
    Biochem Pharmacol; 1997 Jun; 53(12):1901-7. PubMed ID: 9256165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor.
    Morioka Y; Saiga A; Yokota Y; Suzuki N; Ikeda M; Ono T; Nakano K; Fujii N; Ishizaki J; Arita H; Hanasaki K
    Arch Biochem Biophys; 2000 Sep; 381(1):31-42. PubMed ID: 11019817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms that account for the selective release of arachidonic acid from intact cells by secretory phospholipase A2.
    Fonteh AN; Samet JM; Surette M; Reed W; Chilton FH
    Biochim Biophys Acta; 1998 Aug; 1393(2-3):253-66. PubMed ID: 9748613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of tumor necrosis factor alpha-induced secreted phospholipase A2 (sPLA2)-IIA expression in mesangial cells by an autocrine loop involving sPLA2 and peroxisome proliferator-activated receptor alpha activation.
    Beck S; Lambeau G; Scholz-Pedretti K; Gelb MH; Janssen MJ; Edwards SH; Wilton DC; Pfeilschifter J; Kaszkin M
    J Biol Chem; 2003 Aug; 278(32):29799-812. PubMed ID: 12782627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyunsaturated fatty acids potentiate interleukin-1-stimulated arachidonic acid release by cells overexpressing type IIA secretory phospholipase A2.
    Kambe T; Murakami M; Kudo I
    FEBS Lett; 1999 Jun; 453(1-2):81-4. PubMed ID: 10403380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of cyclooxygenase-2 by secretory phospholipases A2 in nerve growth factor-stimulated rat serosal mast cells is facilitated by interaction with fibroblasts and mediated by a mechanism independent of their enzymatic functions.
    Tada K; Murakami M; Kambe T; Kudo I
    J Immunol; 1998 Nov; 161(9):5008-15. PubMed ID: 9794438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of secretory type IIA phospholipase A2 (sPLA2-IIA) as a glycyrrhizin (GL)-binding protein and the GL-induced inhibition of the CK-II-mediated stimulation of sPLA2-IIA activity in vitro.
    Shimoyama Y; Sakamoto R; Akaboshi T; Tanaka M; Ohtsuki K
    Biol Pharm Bull; 2001 Sep; 24(9):1004-8. PubMed ID: 11558558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation between secretory phospholipase A2 and TNF-receptor superfamily signaling: implications for the inflammatory response in atherogenesis.
    Fuentes L; Hernández M; Fernández-Avilés FJ; Crespo MS; Nieto ML
    Circ Res; 2002 Oct; 91(8):681-8. PubMed ID: 12386144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of murine endotoxic shock by sPLA2 inhibitor, indoxam, through group IIA sPLA2-independent mechanisms.
    Yokota Y; Hanasaki K; Ono T; Nakazato H; Kobayashi T; Arita H
    Biochim Biophys Acta; 1999 May; 1438(2):213-22. PubMed ID: 10320804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Group X secretory phospholipase A2 can induce arachidonic acid release and eicosanoid production without activation of cytosolic phospholipase A2 alpha.
    Saiga A; Uozumi N; Ono T; Seno K; Ishimoto Y; Arita H; Shimizu T; Hanasaki K
    Prostaglandins Other Lipid Mediat; 2005 Jan; 75(1-4):79-89. PubMed ID: 15789617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy with interleukin-2 induces the systemic release of phospholipase-A2.
    Wolbink GJ; Schalkwijk C; Baars JW; Wagstaff J; van den Bosch H; Hack CE
    Cancer Immunol Immunother; 1995 Nov; 41(5):287-92. PubMed ID: 8536274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microtubule depolymerization selectively down-regulates the synthesis of proinflammatory secretory nonpancreatic phospholipase A2.
    Pruzanski W; Kennedy BP; van den Bosch H; Stefanski E; Vadas P
    Lab Invest; 1997 Feb; 76(2):171-8. PubMed ID: 9042153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of secretory phospholipase A2 in colon tumor cells potentiates tumor growth.
    Belinsky GS; Rajan TV; Saria EA; Giardina C; Rosenberg DW
    Mol Carcinog; 2007 Feb; 46(2):106-16. PubMed ID: 17091473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Search of factors that intermediate cytokine-induced group IIA phospholipase A2 expression through the cytosolic phospholipase A2- and 12/15-lipoxygenase-dependent pathway.
    Kuwata H; Nonaka T; Murakami M; Kudo I
    J Biol Chem; 2005 Jul; 280(27):25830-9. PubMed ID: 15878884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis.
    Hart PH; Ahern MJ; Smith MD; Finlay-Jones JJ
    Clin Exp Immunol; 1995 Mar; 99(3):331-7. PubMed ID: 7533678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.